Fluconazole 2 Mg/Ml Fresenius 2 mg/mL Solution for infusion
PDF Leaflet Revision Date: 13 February 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of cryptococcal meningitis, systemic candidiasis, and oropharyngeal candidiasis.
Dosage (summary)
Adults: 400 mg on day 1, then 200 mg daily; adjust based on response.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; potential fetal risks.
Key Drug Interactions
- Cisapride
- Terfenadine
- Astemizole
- Pimozide
- Quinidine
- Erythromycin
Contraindications
- Hypersensitivity to fluconazole
- Co-administration with terfenadine at high doses
Common side effects
- Headache
- Nausea
- Abdominal pain
- Diarrhoea
- Rash
Counselling Points
- Monitor for liver function
- Avoid in pregnancy
- Report any rash or allergic reactions
Serious warnings
- QT prolongation
- Hepatotoxicity
- Adrenal insufficiency
Important Disclaimer
The Fluconazole 2 Mg/Ml Fresenius 2 mg/mL Solution for infusion professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
